First of all, we will live longer. A study on survival after Alzheimer’s diagnosis found that people diagnosed at age 65 had ...

Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

An experimental Alzheimer's disease drug from Eisai (4523.T) and Biogen (BIIB.O) slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients ...

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.

The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to ...

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

A new study found that fixing energy balance in the brain reversed symptoms of advanced Alzheimer’s in mice.  Researchers ...

You think you’re fine. Your family and friends think you’re fine. But, just maybe, you’re not. Maybe you already have Alzheimer’s disease, but you just don’t know it yet, because it can begin ...

Routine vaccinations offered to adults may help protect against dementia, recent research has shown.

Finger-prick blood test accurately detects Alzheimer’s biomarkers, enabling at-home collection and broader research ...

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...